While research on hematological malignancies has lagged behind that of solid tumors due to their stronger heterogeneity and complexity, the emergence of single-cell sequencing technology provides a crucial platform for better understanding these diseases. It enables the characterization of tumor cell heterogeneity, clonal evolution, epigenomic variation, the tumor microenvironment composition, and cell interactions, potentially bridging knowledge gaps. Leukemia is a common malignant tumor of the blood system in children, with B-ALL accounting for the majority of cases. Minimal residual disease (MRD) is a key prognostic indicator for pediatric B-ALL, yet detecting low-abundance residual cancer cells remains a technical challenge limiting insights into drug resistance mechanisms maintained by MRD.
We are proud to be able to support your research by generating high-quality, publication-ready data in a rapid time-frame. Reach out to us and we will get back to you shortly.
The field is required.